To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Prognostic value of Alzhe… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.

Journal article
Authors Daniele Altomare
Clarissa Ferrari
Anna Caroli
Samantha Galluzzi
Annapaola Prestia
Wiesje M van der Flier
Rik Ossenkoppele
Bart Van Berckel
Frederik Barkhof
Charlotte E Teunissen
Anders Wall
Stephen F Carter
Michael Schöll
I L Han Choo
Timo Grimmer
Alberto Redolfi
Agneta Nordberg
Philip Scheltens
Alexander Drzezga
Giovanni B Frisoni
Published in Journal of neurology
Volume 266
Issue 10
Pages 2535–2545
ISSN 1432-1459
Publication year 2019
Published at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Wallenberg Centre for Molecular and Translational Medicine
Pages 2535–2545
Language en
Links dx.doi.org/10.1007/s00415-019-09441...
www.ncbi.nlm.nih.gov/entrez/query.f...
Subject categories Neuroscience

Abstract

The aim of this study is to assess the impact of age at onset on the prognostic value of Alzheimer's biomarkers in a large sample of patients with mild cognitive impairment (MCI).We measured Aβ42, t-tau, hippocampal volume on magnetic resonance imaging (MRI) and cortical metabolism on fluorodeoxyglucose-positron emission tomography (FDG-PET) in 188 MCI patients followed for at least 1 year. We categorised patients into earlier and later onset (EO/LO). Receiver operating characteristic curves and corresponding areas under the curve (AUCs) were performed to assess and compar the biomarker prognostic performances in EO and LO groups. Linear Model was adopted for estimating the time-to-progression in relation with earlier/later onset MCI groups and biomarkers.In earlier onset patients, all the assessed biomarkers were able to predict cognitive decline (p < 0.05), with FDG-PET showing the best performance. In later onset patients, all biomarkers but t-tau predicted cognitive decline (p < 0.05). Moreover, FDG-PET alone in earlier onset patients showed a higher prognostic value than the one resulting from the combination of all the biomarkers in later onset patients (earlier onset AUC 0.935 vs later onset AUC 0.753, p < 0.001). Finally, FDG-PET showed a different prognostic value between earlier and later onset patients (p = 0.040) in time-to-progression allowing an estimate of the time free from disease.FDG-PET may represent the most universal tool for the establishment of a prognosis in MCI patients and may be used for obtaining an onset-related estimate of the time free from disease.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://gu.se/english/research/publication/?publicationId=282328
Utskriftsdatum: 2019-11-13